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Abstract 
There is an emerging interest on a subgroup of obese individuals with favourable metabolic 
profile or metabolically healthy obesity (MHO). We discussed two recent publications 
challenging the existence of this obesity subtype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The notion that being obese can be ‘healthy’ has gained emerging interest in the past decade. 
The term metabolically healthy obesity (MHO) refers to a subgroup of obese individuals 
suggested to have favourable metabolic profile in comparison to those with metabolically 
unhealthy obesity (MUO).[1] However, MHO is not a benign condition, with increased risk 
for cardiovascular events compared to the non-obese counterpart.[2] A growing perspective 
sees MHO as a transient state towards metabolic syndrome rather than a distinct 
phenotype,[3,4] but until recently, there had not been exhaustive evidence supporting this 
claim. 
The past month saw two major publications challenging the existence of MHO which we 
consider pivotal to the field. Mongraw-Chaffin and colleagues performed an analysis of 
repeated BMI measurements in the Multi-Ethnic Study of Atherosclerosis (MESA),[5] and 
reported a positive association between  obesity duration and severity and incident metabolic 
syndrome among obese individuals. Ryden and colleagues performed a transcriptomic 
analysis on the subcutaneous white adipose tissue of 51 obese participants of a clinical trial 
evaluating gastric bypass surgery outcomes [6], and reported similar gene expression 
response to insulin between metabolically healthy and unhealthy obese individuals. Despite 
the different approaches used, these two studies arrived at a similar conclusion – that there is 
a full if not partial overlap of those belonging to the metabolically healthy and unhealthy 
obese groups. 
Several issues arise when interpreting these findings. First, criteria used to classify 
individuals into metabolically healthy and unhealthy vary. MESA used the presence of 
metabolic syndrome, whereas the study by Ryden and colleagues classified obese individuals 
by insulin sensitivity measured during a hyperinsulinemic euglycemic clamp. Given the wide 
range of MHO prevalence (6-75%) depending on the definition [7], a consensus is needed to 
define metabolic health. Participant inclusion also posed limitations. Mongraw-Chaffin and 
colleagues included participants with any documented MHO at any point of measurements 
for the primary analysis, and we appreciate that the authors mentioned the lack of information 
on previous history of metabolic syndrome. In the other study, only patients due to undergo a 
gastric bypass surgery were included, thereby limiting generalisability to severely obese 
individuals.  
Secondly, the role of lifestyle, such as smoking and physical activity, has not been explicitly 
addressed, although nicotine consumption did not differ between insulin-sensitive and -
resistant patients in the study by Ryden and colleagues. There is indication that physical 
activity may differentiate MHO and MUO,[8] and adverse obesity-related lifestyles may have 
masked the effect of obesity duration or severity.  
Finally, these studies have yet to answer the question whether MHO is a universal pathway 
between being non-obese and metabolically unhealthy obese, or whether it represents 
individuals with slower progression towards developing metabolic syndrome. Further 
investigations combining longitudinal and experimental approaches may shed light into 
whether a ‘one-for-all’ intervention against obesity is indeed plausible. 
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